

| Catalog No. | HB621013 | ||||
|---|---|---|---|---|---|
| Species reactivity | Human | ||||
| Applications | ELISA | ||||
| Host species | Mouse | ||||
| Isotype | IgG2a, kappa | ||||
| Clone ID | SAA1590 | ||||
| Clonality | Monoclonal | ||||
| Target | 12LO, 12S-LOX, Arachidonate (12S)-lipoxygenase, Platelet-type lipoxygenase 12, LOG12, Arachidonate (15S)-lipoxygenase, Lipoxin synthase 12-LO, Linoleate (13S)-lipoxygenase, 12S-lipoxygenase, ALOX12, Polyunsaturated fatty acid lipoxygenase ALOX12 | ||||
| Endotoxin level | Please contact with the lab for this information. | ||||
| Purity | >95% as determined by SDS-PAGE. | ||||
| Purification | Protein A/G purified from cell culture supernatant. | ||||
| Accession | P18054 | ||||
| RRID | Anti-Human ALOX12 Antibody (SAA1590) (abinScience Cat# HB621013, RRID:AB_3727351) |
||||
| Form | Liquid | ||||
| Storage buffer | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
||||
| Product Usage Information |
| ||||
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. | ||||
| Background | Polyunsaturated fatty acid lipoxygenase ALOX12 is a ~75 kDa protein. Catalyzes the regio and stereo-specific incorporation of molecular oxygen into free and esterified polyunsaturated fatty acids generating lipid hydroperoxides that can be further reduced to the corresponding hydroxy species. Mainly converts arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate) to the specific bioactive lipid (12S)-hydroperoxyeicosatetraenoate/(12S)-HPETE. Through the production of bioactive lipids like (12S)-HPETE it regulates different biological processes including platelet activation. It can also catalyze the epoxidation of double bonds of polyunsaturated fatty acids such as (14S)-hydroperoxy-docosahexaenoate/(14S)-HPDHA resulting in the formation of (13S,14S)-epoxy-DHA. Furthermore, it may participate in the sequential oxidations of DHA ((4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate) to generate specialized pro-resolving mediators (SPMs) like resolvin D5 ((7S,17S)-diHPDHA) and (7S,14S)-diHPDHA, that actively down-regulate the immune response and have anti-aggregation properties with platelets. 1. Prusakiewicz, JJ. et al. (2007) Archives of biochemistry and biophysics 464, 260-8. PMID: 17493578 2. Turman, MV. et al. (2008) Biochemistry 47, 3917-25. PMID: 18311922 3. Hada, T. et al. (1991) Biochimica et biophysica acta 1083, 89-93. PMID: 1851637 4. Perry, SC. et al. (2020) Journal of lipid research 61, 1087-1103. PMID: 32404334 5. Chen, XS. et al. (1993) European journal of biochemistry 214, 845-52. PMID: 8319693 6. Chen, XS. et al. (1993) FASEB journal : official publication of the Federation of American Societies for Experimental Biology 7, 694-701. PMID: 8500694 7. Ikei, KN. et al. (2012) Journal of lipid research 53, 2546-59. PMID: 22984144 8. Horn, T. et al. (2013) Redox biology 1, 566-77. PMID: 24282679 | ||||
| Note | For research use only. |

SDS-PAGE for Anti-Human ALOX12 Antibody (SAA1590)
Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com


+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский